Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
38,539,454
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
6,679,955
-
Shares change
-
+4,493,846
-
Total reported value, excl. options
-
$129,181,455
-
Value change
-
+$89,131,352
-
Put/Call ratio
-
70%
-
Number of buys
-
64
-
Number of sells
-
-20
-
Price
-
$19.35
Significant Holders of Co-Diagnostics, Inc. - Common Stock (CODX) as of Q2 2020
104 filings reported holding CODX - Co-Diagnostics, Inc. - Common Stock as of Q2 2020.
Co-Diagnostics, Inc. - Common Stock (CODX) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,679,955 shares
of 38,539,454 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,801,790 shares), VANGUARD GROUP INC (1,302,263 shares), STATE STREET CORP (476,111 shares), GEODE CAPITAL MANAGEMENT, LLC (330,448 shares), NORTHERN TRUST CORP (307,535 shares), CITADEL ADVISORS LLC (279,236 shares), Nuveen Asset Management, LLC (222,500 shares), MORGAN STANLEY (165,894 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (145,362 shares), and BARCLAYS PLC (144,171 shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.